Cargando…
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
BACKGROUND: WISDOM (Women Informed to Screen Depending on Measures of Risk) is a randomized trial to assess whether personalized breast cancer screening—where women are screened biannually, annually, biennially, or not at all depending on risk and age—can prevent as many advanced (stage IIB or highe...
Autores principales: | Eklund, Martin, Broglio, Kristine, Yau, Christina, Connor, Jason T, Stover Fiscalini, Allison, Esserman, Laura J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649825/ https://www.ncbi.nlm.nih.gov/pubmed/31360882 http://dx.doi.org/10.1093/jncics/pky067 |
Ejemplares similares
-
Response to Carter et al.
por: Eklund, Martin, et al.
Publicado: (2020) -
RE: The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
por: Carter, Kimbroe, et al.
Publicado: (2020) -
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study
por: Wang, Tianyi, et al.
Publicado: (2023) -
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
por: Esserman, Laura J.
Publicado: (2017) -
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
por: Keane, Holly, et al.
Publicado: (2021)